The global Retinitis Pigmentosa (RP) Market is gaining increasing attention as advancements in genetic research, precision medicine, and innovative therapeutic approaches reshape the treatment landscape for inherited retinal disorders. Valued at US$ 14,789.90 million in 2024, the market is projected to expand at a CAGR of 7.4% from 2025 to 2032. Growing awareness about rare genetic eye...